Mebucain Mint (Cetylpyridinium Chloride, Lidocaine Hydrochloride)

Lidocaine hydrochloride blocks voltage‑gated sodium channels on peripheral nerves, preventing the transmission of pain signals and producing a numbing effect. Cetylpyridinium chloride is a cationic surfactant that disrupts bacterial cell membranes, leading to rapid antimicrobial activity. Together they provide both analgesic and antiseptic benefits in the oral cavity.

The appropriate dose of Mebucain Mint is determined by the prescribing healthcare professional or according to the product label. Typical OTC instructions advise applying a measured amount to the affected area or using the product as a mouth rinse for a short period, but exact dosing should always follow the guidance provided by a qualified practitioner.

Safety data for cetylpyridinium chloride and lidocaine hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Mebucain Mint to weigh potential benefits against any uncertain risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Mebucain Mint combines lidocaine, a longer‑acting amide anesthetic, with cetylpyridinium chloride, an antiseptic. Benzocaine products typically contain only a short‑acting ester anesthetic and lack antimicrobial activity. Consequently, Mebucain Mint may offer more prolonged numbness and added protection against oral bacteria, while both classes share similar safety profiles when used as directed.

Store Mebucain Mint at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, direct sunlight and extreme heat. Ensure the cap is tightly closed after each use to maintain stability and prevent contamination.

Mebucain Mint is applied directly to the oral mucosa or used as a short‑duration mouth rinse, depending on the product format. The user should follow the label instructions or the prescribing clinician’s guidance, typically applying a measured amount to the affected area or swishing the rinse for the recommended time before expectorating.

The most serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and rare systemic toxicity from lidocaine absorption, which can manifest as dizziness, irregular heartbeat, or seizures. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to lidocaine, cetylpyridinium chloride, or any component of the formulation should avoid Mebucain Mint. It is also not recommended for children under two years of age without medical supervision, and persons taking other topical anesthetics or anticoagulant therapy should consult a healthcare professional before use.